A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Abroad (travel likely)RecruitingPHASE3

Conditions

Rifampin-Resistant Pulmonary Tuberculosis · Tuberculosis, Multidrug-Resistant (MDR-TB)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Chest Hospital affiliated to Capital Medical University, Beijing, Beijing Municipality, China
Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Chu Nai Hui, M.D) · dongchu@sina.com · +86-010-89509312

Study leads

Naihui Chu, Ph.D
Principal Investigator
Beijing Chest Hospital affiliated to Capital Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Novel Triple-dose Tuberculosis Retreatment Regimen

Multidrug-resistant Tuberculosis · Pulmonary Tuberculosis · Tuberculosis

Abroad (travel likely)RecruitingPHASE3

Niamey, Niger

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Tuberculosis · Multidrug Resistant Pulmonary Tuberculosis · Rifampicin-resistant Tuberculosis

Abroad (travel likely)RecruitingPHASE2

Wuhan, China · Changsha, China

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Tuberculosis, Pulmonary · Tuberculosis, Multidrug-Resistant · Tuberculosis, MDR

Abroad (travel likely)RecruitingPHASE2, PHASE3

Ulaanbaatar, Mongolia · Kotri, Pakistan

A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Pulmonary Tuberculosis

Abroad (travel likely)RecruitingPHASE3

Beijing, China · Fuzhou, China